Effects of Different Flow Anesthesia on Atelectasis
Evaluation Of Peroperative Atelectasis In Minimal, Low And Medium Flow Anesthesia By Lung Ultrasound Score
1 other identifier
observational
1
1 country
1
Brief Summary
Evaluation of atelectasis that may be caused by different flow rate anesthesia applications during the operation with lung ultrasound score.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFirst Submitted
Initial submission to the registry
April 21, 2022
CompletedFirst Posted
Study publicly available on registry
May 19, 2022
CompletedMay 19, 2022
May 1, 2022
12 months
April 21, 2022
May 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
assessment of lung ultrasound score
Effect of different flow anesthesia on lung ultrasound score
Change from Baseline and 30 minute after emergence
Study Arms (3)
Group I
Minimal Flow Anesthesia (0.25L/dk oxygen, 0,25 L/min air)
Group II
Low Flow Anesthesia (0.5L/dk oxygen, 0,5 L/min air)
Group III
Medium Flow Anesthesia (1L/dk oxygen, 1 L/min air
Interventions
Measuring the atelectasis area by ultrasound guidance from 12 different regions of the lung
Eligibility Criteria
ASA I-II septoplasty and rhinoplasty patients aged 18-65 years
You may qualify if:
- operation time 2-5 hours
- elective septoplasty and rhinoplasty
- ASA I-II
You may not qualify if:
- morbid obesity
- malignant hyperthermia
- opioid sensitivity
- alcohol or drug addiction
- congestive heart failure
- chronic obstructive pulmonary disease
- coronary artery disease
- anemia
- liver and kidney diseases
- pregnancy
- breast-feeding
- history of allergy to drugs used
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zonguldak Bülent Ecevit University Faculty of Medicine
Zonguldak, Kozlu, 67600, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiologist
Study Record Dates
First Submitted
April 21, 2022
First Posted
May 19, 2022
Study Start
January 1, 2021
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
May 19, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will share